ClinicalTrials.Veeva

Menu

Increasing PrEP Among African Americans in Louisville KY

University of Louisville (UOFL) logo

University of Louisville (UOFL)

Status

Completed

Conditions

HIV/AIDS PREVENTION

Treatments

Behavioral: Project Prevent

Study type

Interventional

Funder types

Other

Identifiers

NCT03559595
18.0020

Details and patient eligibility

About

This study evaluates the effectiveness of a multifaceted strategy to increase pre-exposure prophylaxis (PrEP; a medication regimen to reduce HIV risk) uptake among high risk African Americans in Louisville, KY. We will do this by 1) implementing a media campaign to raise awareness about PrEP, 2) providing PrEP education to medical personnel who can prescribe PrEP, and 3) partnering with AIDS service organizations to improve outreach and linkage to PrEP services.

Enrollment

205 patients

Sex

All

Ages

18 to 29 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Between ages 18-29 years old
  • Self-identifies as African American or Black
  • Resident of Louisville, KY
  • Member of a priority group for PrEP HIV prevention (Men who have sex with men, people who inject drugs, trans women, high risk heterosexuals, people in serodiscordant relationships).
  • Not diagnosed with HIV

Exclusion criteria

  • Older than 29 and younger than 18 years old
  • Does not identify as African American or Black
  • Does not reside in Louisville, KY
  • Not a member of a priority group
  • Diagnosed with HIV

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

205 participants in 1 patient group

Intervention group
Experimental group
Description:
All study participants will be exposed to the intervention
Treatment:
Behavioral: Project Prevent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems